JACQUELINE VERCAUTEREN: Open Payments
NPI 1467061697 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 59 payments from 20 companies in 2025. Trend: 2023 $1,055 · 2024 $1,510 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $199 |
| Botanix SB Inc | 4 | $183 |
| Janssen Biotech, Inc. | 12 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $165 |
| Verrica Pharmaceuticals Inc. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| PFIZER INC. | 3 | $72 |
| ABBVIE INC. | 3 | $56 |
| Amgen Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
Products named: Bimzelx, SOFDRA, TREMFYA, YCANTH, Winlevi, COSENTYX, CIBINQO, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
